Business Description
Pharmosa Biopharm Inc
ISIN : TW0006875008
Description
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 13.85 | |||||
Equity-to-Asset | 0.9 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | 2.18 | |||||
Piotroski F-Score | 7/9 | |||||
Altman Z-Score | 22.2 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year FCF Growth Rate | 55.3 | |||||
3-Year Book Growth Rate | 5.3 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 53.08 | |||||
9-Day RSI | 53.98 | |||||
14-Day RSI | 51.56 | |||||
6-1 Month Momentum % | -49.15 | |||||
12-1 Month Momentum % | -35.47 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 16.29 | |||||
Quick Ratio | 15.97 | |||||
Cash Ratio | 15.7 | |||||
Days Inventory | 1500.45 | |||||
Days Payable | 135.97 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -33.9 | |||||
Shareholder Yield % | -17.79 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 97.88 | |||||
Operating Margin % | -3.04 | |||||
Net Margin % | 8.57 | |||||
FCF Margin % | -28.85 | |||||
ROE % | 1.97 | |||||
ROA % | 1.74 | |||||
ROIC % | -3.02 | |||||
ROC (Joel Greenblatt) % | 18.2 | |||||
ROCE % | 2.06 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 193.55 | |||||
PE Ratio without NRI | 193.55 | |||||
Price-to-Owner-Earnings | 304.82 | |||||
PS Ratio | 21.11 | |||||
PB Ratio | 3.89 | |||||
Price-to-Tangible-Book | 3.89 | |||||
Price-to-Operating-Cash-Flow | 98.85 | |||||
EV-to-EBIT | 195.74 | |||||
EV-to-EBITDA | 105.4 | |||||
EV-to-Revenue | 18.87 | |||||
EV-to-FCF | -67.5 | |||||
Price-to-Graham-Number | 5.78 | |||||
Price-to-Net-Current-Asset-Value | 4.87 | |||||
Price-to-Net-Cash | 5.08 | |||||
Earnings Yield (Greenblatt) % | 0.52 | |||||
FCF Yield % | -1.21 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Pharmosa Biopharm Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil NT$) | 324.117 | ||
EPS (TTM) (NT$) | 0.31 | ||
Beta | 0 | ||
Volatility % | 51.06 | ||
14-Day RSI | 51.56 | ||
14-Day ATR (NT$) | 3.364481 | ||
20-Day SMA (NT$) | 56.1475 | ||
12-1 Month Momentum % | -35.47 | ||
52-Week Range (NT$) | 48.25 - 125.5 | ||
Shares Outstanding (Mil) | 129.02 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 7 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Pharmosa Biopharm Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Pharmosa Biopharm Inc Stock Events
Event | Date | Price(NT$) | ||
---|---|---|---|---|
No Event Data |
Pharmosa Biopharm Inc Frequently Asked Questions
What is Pharmosa Biopharm Inc(ROCO:6875)'s stock price today?
When is next earnings date of Pharmosa Biopharm Inc(ROCO:6875)?
Does Pharmosa Biopharm Inc(ROCO:6875) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |